News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
8
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
308
|
|
Created
|
02/23/07
|
Type
|
Free
|
| Moderators | |||
Auriga Laboratories
Auriga Laboratories™ develops pharmaceutical products based on patented drug delivery technologies in cellular biology, material science, and pharmaceutics. It offers Extendryl, which is used for the treatment of cough and cold medications, and allergy symptoms. The company also offers products for the treatment of gastrointestinal disorders and central nervous system disorders, including pain control. Auriga Laboratories is based in Norcross, Georgia. Auriga Laboratories™ is a specialty pharmaceutical company building an industry changing commission based-sales model. The company's high-growth business model combines driving revenues through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline, all of which is designed to enhance its growing direct relationships with physicians nationwide.
Auriga Laboratories™ Inc. is a sales-focused specialty pharmaceutical company capitalizing on high-revenue markets and opportunities in the pharmaceutical industry through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline. We are currently focused on delivering unique solutions for the respiratory, dermatology, and xerostomia (dry mouth) markets and enhancing our relationships with physicians nationwide.
Auriga's founders and management team are experts in managing the full life cycle of bringing a new medication to market - from pipeline development and formulation to final sales. Our drug development pipeline leverages novel material science and advanced drug delivery technologies to produce improved formulations of successful brands to further expand markets and sales for proven, successful products.
Auriga Milestones:
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800
Golden, CO 80401
Share Structure
250,000,000 Shares Authorized
79,536,557 Outstanding Shares as of May 12, 2008
Company Website
http://www.aurigalabs.com
805-437-7200
investors@aurigalabs.com
